World's Best Scientists 2026 revealed!
Taisei Mushiroda

Taisei Mushiroda

D-Index & Metrics

Biology and Biochemistry

D-Index
56
Citations
10346
World Ranking
14517
National Ranking
1025

Overview

Taisei Mushiroda is affiliated with RIKEN in Japan and has made contributions primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their research spans multiple subfields, notably Pharmacology, Molecular Biology, Genetics, Oncology, and Infectious Diseases.

The scientist's work covers several main topics, including Pharmacogenetics and Drug Metabolism, Drug-Induced Adverse Reactions, Computational Drug Discovery Methods, Drug Transport and Resistance Mechanisms, Genetic Associations and Epidemiology, Autoimmune Bullous Skin Diseases, and Blood disorders and treatments.

Taisei Mushiroda has published research in a range of scholarly venues. Frequent publication sites include:

  • Journal of Investigative Dermatology
  • Journal of Human Genetics
  • Clinical Pharmacology & Therapeutics
  • Scientific Reports
  • Blood

Recent papers authored or co-authored by Mushiroda cover diverse topics and publication years, such as:

  • Genomewide Meta-Analysis Validates a Role for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy, 2020, Clinical Pharmacology & Therapeutics
  • Genome-wide host-pathogen analyses reveal genetic interaction points in tuberculosis disease, 2023, Nature Communications
  • Prevalence of pharmacogenomic variants in 100 pharmacogenes among Southeast Asian populations under the collaboration of the Southeast Asian Pharmacogenomics Research Network (SEAPharm), 2021, Human Genome Variation
  • Variation in 100 relevant pharmacogenes among emiratis with insights from understudied populations, 2020, Scientific Reports
  • Association of HLA-A*11:01 with Sulfonamide-Related Severe Cutaneous Adverse Reactions in Japanese Patients, 2020, Journal of Investigative Dermatology

Frequent co-authors collaborating with Mushiroda include:

  • Koya Fukunaga
  • Yukihide Momozawa
  • Keiko Hikino
  • Michiaki Kubo
  • Chikashi Terao

Best Publications

  • Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population

    Takeshi Ozeki;Taisei Mushiroda;Amara Yowang;Atsushi Takahashi

  • Overview of the BioBank Japan Project: Study design and profile

    Akiko Nagai;Makoto Hirata;Yoichiro Kamatani;Kaori Muto

  • A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis.

    T Mushiroda;S Wattanapokayakit;A Takahashi;T Nukiwa

  • Genetic variants associated with warfarin dose in African- American individuals: a genome-wide association study

    Minoli A Perera;Larisa H Cavallari;Nita A Limdi;Eric R Gamazon

  • Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update

    Elizabeth J. Phillips;Chonlaphat Sukasem;Michelle Whirl-Carrillo;Daniel J. Müller

  • Significant Effect of Polymorphisms in CYP2D6 and ABCC2 on Clinical Outcomes of Adjuvant Tamoxifen Therapy for Breast Cancer Patients

    Kazuma Kiyotani;Taisei Mushiroda;Chiyo K. Imamura;Naoya Hosono

  • Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy.

    Kazuma Kiyotani;Taisei Mushiroda;Mitsunori Sasa;Yoshimi Bando

  • A genome-wide association identified the common genetic variants influence disease severity in β0-thalassemia/hemoglobin E

    Manit Nuinoon;Wattanan Makarasara;Taisei Mushiroda;Iswari Setianingsih

  • Genome-wide Associations and Functional Genomic Studies of Musculoskeletal Adverse Events in Women Receiving Aromatase Inhibitors

    James N. Ingle;Daniel J. Schaid;Paul E. Goss;Mohan Liu

  • HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients.

    Soranun Chantarangsu;Taisei Mushiroda;Surakameth Mahasirimongkol;Sasisopin Kiertiburanakul

  • Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients

    Taisei Mushiroda;Yozo Ohnishi;Susumu Saito;Atsushi Takahashi

  • Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia.

    Kazuma Kiyotani;Taisei Mushiroda;Michiaki Kubo;Hitoshi Zembutsu

  • Genome-wide association study identifies genetic determinants of warfarin responsiveness for Japanese

    Pei Chieng Cha;Taisei Mushiroda;Atsushi Takahashi;Michiaki Kubo

  • Cross-sectional analysis of BioBank Japan clinical data: A large cohort of 200,000 patients with 47 common diseases.

    Makoto Hirata;Yoichiro Kamatani;Akiko Nagai;Yutaka Kiyohara

  • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA‐B) genotype and allopurinol dosing: 2015 update

    Y. Saito;L.K. Stamp;K.E. Caudle;Hershfield

  • Genome-wide association studies of tuberculosis in Asians identify distinct at-risk locus for young tuberculosis

    Surakameth Mahasirimongkol;Surakameth Mahasirimongkol;Hideki Yanai;Taisei Mushiroda;Watoo Promphittayarat

  • Case-control association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population.

    Elitza T. Betcheva;Taisei Mushiroda;Atsushi Takahashi;Michiaki Kubo

  • Pharmacogenomics of tamoxifen: roles of drug metabolizing enzymes and transporters.

    Kazuma Kiyotani;Taisei Mushiroda;Yusuke Nakamura;Hitoshi Zembutsu

  • A genome-wide association study identifies ITGA9 conferring risk of nasopharyngeal carcinoma.

    Ching Ching Ng;Poh Yin Yew;Suat Moi Puah;Gopala Krishnan

  • Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Human Leukocyte Antigen B (HLA-B) Genotype and Allopurinol Dosing: 2015 update

    Yoshiro Saito;Lisa K. Stamp;Kelly E. Caudle;Michael Hershfield

Frequent Co-Authors

Yusuke Nakamura
Yusuke Nakamura National Institutes of Biomedical Innovation, Health and Nutrition
Naoyuki Kamatani
Naoyuki Kamatani StaGen (Japan)
Eric R. Gamazon
Eric R. Gamazon Vanderbilt University Medical Center
M. Eileen Dolan
M. Eileen Dolan University of Chicago
Katsushi Tokunaga
Katsushi Tokunaga University of Tokyo
Nancy J. Cox
Nancy J. Cox Vanderbilt University Medical Center
Liewei Wang
Liewei Wang Mayo Clinic
Naoya Hosono
Naoya Hosono University of Tokyo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry opens doors to a diverse set of careers across the health, research, and administrative sectors. For those eager to expand their qualifications, numerous accredited online programs can pave the way for career advancement or specialization.

Individuals interested in nutrition and public health can explore pursuing an online nutritionist degree. This pathway equips students for roles in community health, wellness clinics, or private consultancy.

Aspiring healthcare managers may look into cahme-accredited online mha programs, preparing graduates for leadership positions within hospitals, clinics, or healthcare systems.

Those already holding nursing credentials can consider the flexibility of an msn to dnp online no clinicals route, enabling them to advance practice and impact healthcare policy without on-site clinical requirements.

For professionals seeking top-tier positions in healthcare leadership, a doctorate in healthcare administration online provides the expertise and credentials to drive organizational change.

Exploring these related online degrees can help students tailor their educational journey to specific career goals within biology, biochemistry, and the broader healthcare field.

Best Scientists Citing Taisei Mushiroda

Trending Scientists

Recently Published Articles